Related Experiment Video
Updated: Apr 14, 2026

12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
35.8K
Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation
Joseph M Reynolds1, Young-Hee Lee2, Yun Shi2
1Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Immunity
|April 19, 2015
Summary
Interleukin-17B (IL-17B) inhibits inflammation driven by Interleukin-25 (IL-25), acting as a protective cytokine. This discovery reveals opposing roles for IL-17B and IL-25 in inflammatory diseases.
Area of Science:
- Immunology
- Inflammation Research
Background:
- The interleukin-17 (IL-17) cytokine family plays a key role in inflammatory diseases.
- Interleukin-25 (IL-25) is known for its involvement in allergic inflammation and parasitic infection defense.
- Interleukin-17B (IL-17B) is a less understood member of the IL-17 family.
Purpose of the Study:
- To investigate the function of IL-17B in the context of IL-25-driven inflammation.
- To elucidate the opposing roles of IL-17B and IL-25 in inflammatory conditions.
Main Methods:
- Analyzing cytokine expression in acute colonic inflammation models.
- Examining the effects of individual IL-17B and IL-25 inhibition in disease models.
- Assessing IL-6 production by colon epithelial cells.
Main Results:
- Both IL-17B and IL-25 were upregulated during acute colonic inflammation.
- IL-25 demonstrated pathogenic effects, while IL-17B showed protective functions in colon inflammation.
- Opposing roles were observed in Citrobacter rodentium infection and allergic asthma models.
- IL-25 promoted IL-6 production, which was suppressed by IL-17B.
Conclusions:
- IL-17B acts as an anti-inflammatory cytokine within the IL-17 family.
- IL-17B counteracts the pro-inflammatory actions of IL-25.
- These findings highlight a novel regulatory mechanism in IL-17-mediated inflammation.
Related Concept Videos
T Cell Types and Functions
3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K

